Antimicrobial resistance and reduced susceptibility in Clostridium difficile: potential consequences for induction, treatment, and recurrence of C. difficile infection.

Simon D. Baines, M. H. Wilcox

Research output: Contribution to journalArticlepeer-review

45 Citations (Scopus)
282 Downloads (Pure)

Abstract

Clostridium difficile infection (CDI) remains a substantial burden on healthcare systems and is likely to remain so given our reliance on antimicrobial therapies to treat bacterial infections, especially in an aging population in whom multiple co-morbidities are common. Antimicrobial agents are a key component in the aetiology of CDI, both in the establishment of the infection and also in its treatment. The purpose of this review is to summarise the role of antimicrobial agents in primary and recurrent CDI; assessing why certain antimicrobial classes may predispose to the induction of CDI according to a balance between antimicrobial activity against the gut microflora and C. difficile. Considering these aspects of CDI is important in both the prevention of the infection and in the development of new antimicrobial treatments.
Original languageEnglish
Article number4030267
Pages (from-to)267-298
Number of pages32
JournalAntibiotics
Volume4
Issue number3
DOIs
Publication statusPublished - 10 Jul 2015

Keywords

  • Clostridium difficile
  • antimicrobial agents
  • resistance
  • reduced susceptibility
  • recurrence

Fingerprint

Dive into the research topics of 'Antimicrobial resistance and reduced susceptibility in Clostridium difficile: potential consequences for induction, treatment, and recurrence of C. difficile infection.'. Together they form a unique fingerprint.

Cite this